Quest Partners LLC Purchases Shares of 269 Addus HomeCare Co. (NASDAQ:ADUS)

Quest Partners LLC purchased a new stake in Addus HomeCare Co. (NASDAQ:ADUS) during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 269 shares of the company’s stock, valued at approximately $31,000.

Other large investors have also recently bought and sold shares of the company. Ellsworth Advisors LLC bought a new stake in Addus HomeCare in the second quarter valued at $598,000. Dean Capital Management acquired a new position in Addus HomeCare in the fourth quarter worth $652,000. Quadrature Capital Ltd acquired a new position in Addus HomeCare in the first quarter worth $1,557,000. Lord Abbett & CO. LLC acquired a new position in Addus HomeCare in the first quarter worth $8,274,000. Finally, Vanguard Group Inc. boosted its stake in Addus HomeCare by 3.2% in the fourth quarter. Vanguard Group Inc. now owns 1,257,440 shares of the company’s stock worth $116,753,000 after purchasing an additional 38,876 shares in the last quarter. 95.35% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Addus HomeCare

In other Addus HomeCare news, EVP Michael D. Wattenbarger sold 21,917 shares of the stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $133.29, for a total value of $2,921,316.93. Following the transaction, the executive vice president now owns 7,215 shares of the company’s stock, valued at $961,687.35. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. In other Addus HomeCare news, EVP Michael D. Wattenbarger sold 21,917 shares of the stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $133.29, for a total value of $2,921,316.93. Following the transaction, the executive vice president now owns 7,215 shares of the company’s stock, valued at $961,687.35. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, Director Esteban Lopez sold 500 shares of the stock in a transaction dated Tuesday, September 10th. The stock was sold at an average price of $127.50, for a total value of $63,750.00. Following the completion of the sale, the director now owns 3,366 shares of the company’s stock, valued at $429,165. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 22,917 shares of company stock valued at $3,050,082. 4.60% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on the company. Oppenheimer boosted their price objective on Addus HomeCare from $130.00 to $140.00 and gave the stock an “outperform” rating in a research note on Wednesday, August 7th. Macquarie assumed coverage on Addus HomeCare in a research note on Friday, June 28th. They issued an “outperform” rating and a $136.00 price objective on the stock. Stephens reissued an “overweight” rating and issued a $138.00 price objective on shares of Addus HomeCare in a research note on Tuesday, August 6th. TD Cowen boosted their price objective on Addus HomeCare from $128.00 to $137.00 and gave the stock a “buy” rating in a research note on Thursday, August 8th. Finally, Royal Bank of Canada reaffirmed an “outperform” rating and set a $141.00 price target on shares of Addus HomeCare in a research note on Tuesday, September 3rd. One equities research analyst has rated the stock with a sell rating and eight have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $127.57.

Addus HomeCare Stock Up 0.4 %

Shares of ADUS opened at $133.05 on Friday. Addus HomeCare Co. has a 12-month low of $78.35 and a 12-month high of $136.12. The firm has a market capitalization of $2.41 billion, a PE ratio of 33.01, a price-to-earnings-growth ratio of 2.33 and a beta of 1.04. The stock’s fifty day simple moving average is $126.62 and its 200-day simple moving average is $113.68.

Addus HomeCare (NASDAQ:ADUS) last released its earnings results on Monday, August 5th. The company reported $1.35 earnings per share for the quarter, beating the consensus estimate of $1.21 by $0.14. Addus HomeCare had a return on equity of 9.81% and a net margin of 6.18%. The firm had revenue of $286.90 million for the quarter, compared to analyst estimates of $284.90 million. During the same quarter in the prior year, the firm posted $0.94 earnings per share. The company’s quarterly revenue was up 10.4% on a year-over-year basis. Analysts anticipate that Addus HomeCare Co. will post 4.58 EPS for the current year.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.